跳至主要内容
临床试验/NCT04740840
NCT04740840已完成2 期

Comparison of Anti-inflammatory Effects of Amlodipine and Levamlodipine in Patients With Hypertension

Affiliated Hospital of North Sichuan Medical College0 个研究点目标入组 200 人开始时间: 2010年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200
主要终点
After treatment, the blood pressure control of L-amlodipine group was better than that of amlodipine group

研究概览

简要总结

To investigate the anti-inflammatory effect of amlodipine and levamlodipine in the treatment of hypertension

详细描述

A total of 200 inpatients or outpatients in the Department of cardiovascular medicine of the third people's Hospital of Mianyang City from April 2021 to October 2021, who met the diagnostic criteria of ish2020 international hypertension practice guidelines, were selected and randomly divided into control group and experimental group, with 100 cases in each group. The control group was treated with amlodipine and the experimental group was treated with levoamlodipine. The changes of blood pressure and serum inflammatory factors were observed before and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ① In line with the diagnostic criteria of ISH2020 International Guidelines for Practice of Hypertension ② Age >18 years old, gender is not limited, during the treatment did not take other drugs that will affect blood pressure: such as antidepressants, oral contraceptives, Chinese herbal medicine, etc.; Voluntary participation and signing of informed consent, and can complete all the visit plan.

排除标准

  • (1) Those who do not want to take blood tests; (2) Left ventricular ejection fraction < 50%, heart rate <50 beats/min; ③ Acute coronary syndrome (unstable angina pectoris and myocardial infarction); ④ valvular heart disease, congenital heart disease, etc.; Other infectious diseases and malignant tumors; ⑥ Bronchial asthma; ⑦ Abnormal liver function and renal dysfunction (ALT BBB 0 80U/L, CR BBB 1 442mmol/L); Autoimmune diseases or any serious and fatal diseases; ⑨ Receiving lipid-lowering therapy and oral vitamins or antioxidants; They are mentally ill, have no self-awareness, and are unable to express themselves or cooperate with others.

研究组 & 干预措施

Levamlodipine group

Experimental

Blood pressure lowering therapy with 2.5mg levamlodipine, plus metoprolol succinate

干预措施: Levamlodipine (Drug)

Amlodipine group

Sham Comparator

To receive 5mg amlodipine to lower blood pressure, plus metoprolol succinate

干预措施: Amlodipine (Drug)

结局指标

主要结局

After treatment, the blood pressure control of L-amlodipine group was better than that of amlodipine group

时间窗: One month after treatment

the serum inflammatory factor level of L-amlodipine group was lower than that of amlodipine group

时间窗: One month after treatment

Serum ATP level can be used to evaluate the anti-inflammatory effect of hypertension drugs

时间窗: One month after treatment

次要结局

未报告次要终点

研究者

发起方
Affiliated Hospital of North Sichuan Medical College
申办方类型
Other
责任方
Sponsor

相似试验